Page last updated: 2024-12-08

alpinetin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

alpinetin: from Alpinia henryi K. Schum.; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AlpiniagenusA plant genus of the family ZINGIBERACEAE. Members contain galangin, yakuchinone-A, and diarylheptanoids.[MeSH]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]
Alpinia henryispecies[no description available]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]

Cross-References

ID SourceID
PubMed CID4053302
CHEMBL ID427218
CHEBI ID192656
SCHEMBL ID1460823
MeSH IDM0401657

Synonyms (20)

Synonym
AC-20180
1090-65-9
alpinetin
MEGXP0_000549
LMPK12140215
CHEMBL427218
7-hydroxy-5-methoxy-2-phenyl-3,4-dihydro-2h-1-benzopyran-4-one
CHEBI:192656
7-hydroxy-5-methoxy-2-phenyl-2,3-dihydrochromen-4-one
5-methoxy-7-hydroxyflavanone
SCHEMBL1460823
7-hydroxy-5-methoxy-2-phenylchroman-4-one
FT-0630589
AKOS015914785
7-hydroxy-5-methoxy-2-phenyl-chroman-4-one
QQQCWVDPMPFUGF-UHFFFAOYSA-N
DTXSID30398801
2,3-dihydro-7-hydroxy-5-methoxy-2-phenyl-4h-1-benzopyran-4-one
B2703-091011
(2s)-alpinetin

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The new developed method was subsequently applied to a pharmacokinetic research of alpinetin following oral and intravenous dosing to healthy Sprague-Dawley rats."( Quantification and pharmacokinetics of alpinetin in rat plasma by UHPLC-MS/MS using protein precipitation coupled with dilution approach to eliminate matrix effects.
Bao, S; Chen, R; Lin, X; Sun, R; Wang, X; Wen, C; Xu, Y; Ye, W; Zhang, Y, 2018
)
0.48

Bioavailability

ExcerptReferenceRelevance
" Alpinetin was demonstrated rapid absorption after oral administration with an absolute bioavailability of ∼15."( Quantification and pharmacokinetics of alpinetin in rat plasma by UHPLC-MS/MS using protein precipitation coupled with dilution approach to eliminate matrix effects.
Bao, S; Chen, R; Lin, X; Sun, R; Wang, X; Wen, C; Xu, Y; Ye, W; Zhang, Y, 2018
)
0.48

Dosage Studied

ExcerptRelevanceReference
" The new developed method was subsequently applied to a pharmacokinetic research of alpinetin following oral and intravenous dosing to healthy Sprague-Dawley rats."( Quantification and pharmacokinetics of alpinetin in rat plasma by UHPLC-MS/MS using protein precipitation coupled with dilution approach to eliminate matrix effects.
Bao, S; Chen, R; Lin, X; Sun, R; Wang, X; Wen, C; Xu, Y; Ye, W; Zhang, Y, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
flavonoidsAny organic molecular entity whose stucture is based on derivatives of a phenyl-substituted 1-phenylpropane possessing a C15 or C16 skeleton, or such a structure which is condensed with a C6-C3 lignan precursors. The term is a 'superclass' comprising all members of the classes of flavonoid, isoflavonoid, neoflavonoid, chalcones, dihydrochalcones, aurones, pterocarpan, coumestans, rotenoid, flavonolignan, homoflavonoid and flavonoid oligomers. Originally restricted to natural products, the term is also applied to synthetic compounds related to them.
etherAn organooxygen compound with formula ROR, where R is not hydrogen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1434690Inhibition of sucrose loaded POPC/POPE/POPS/PtdIns(3,4,5)P3 (59:20:20:1) liposome binding to eGFP-fused PDK1 PH domain (unknown origin) expressed in Escherichia coli BL21 at 20 uM after 10 mins by fluorescence spectrophotometry based pull down assay relat2017Bioorganic & medicinal chemistry letters, 02-01, Volume: 27, Issue:3
Inhibitory potential of flavonoids on PtdIns(3,4,5)P3 binding with the phosphoinositide-dependent kinase 1 pleckstrin homology domain.
AID353303Increase in EGR1 mRNA expression in human HEK293 cells at 20 ug/mL after 6 to 12 hrs by dual-glo luciferase assay relative to control2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Relationships between the structures of flavanone derivatives and their effects in enhancing early growth response-1 gene expression.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (58)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (15.52)29.6817
2010's32 (55.17)24.3611
2020's17 (29.31)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other59 (98.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]